The Human Immunology Core is now fully open for new or ongoing projects prioritized by the HIC in accordance with Penn’s Research Resumption Plan and PSOM policies.
Primary cell ordering has resumed with one donor on Tuesday and one donor on Thursday, every week. Details are provided when you click on “primary cells” on the “requesting services” tab.
Sample processing cut-off times are strictly observed. Please e-mail Ling Zhao (firstname.lastname@example.org) for additional policies and specific directions, or questions about project prioritization.
For cellular immunology assays please e-mail Ling Zhao (email@example.com) regarding new projects, or project resumption or prioritization.
For molecular immunology assays please e-mail Wenzhao Meng (firstname.lastname@example.org) regarding new projects, or project resumption or prioritization.
For COVID-19 projects, please e-mail Nina Luning Prak (email@example.com).
The Human Immunology Core (HIC) serves as a central facility to provide wet bench expertise for the incorporation of the newest technologies into phase I/II clinical trials using validated immunology assays, while also offering expert scientific and technical consultation to investigators conducting translational research.
Feel free to contact us with any questions.
Digital ELISA (Simoa HD-1)
For further information, please contact Ling Zhao